Mar 6, 2026 12:51PM
Mar 5, 2026 04:05PM
Feb 4, 2026 08:00AM
Dec 24, 2025 06:00AM
Dec 24, 2025 06:00AM
Dec 1, 2025 04:05PM
Nov 13, 2025 04:47AM Caribou Biosciences Inc. (CRBU) PT Raised to $4 at Leerink Partners
Nov 12, 2025 04:05PM
Nov 3, 2025 07:02AM
Nov 3, 2025 07:01AM
Nov 3, 2025 07:00AM
Nov 3, 2025 07:00AM
Nov 2, 2025 04:00PM
Aug 12, 2025 04:05PM Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update
May 8, 2025 04:05PM
Apr 24, 2025 04:16PM
Apr 24, 2025 04:15PM
Mar 10, 2025 04:05PM
Jan 12, 2025 07:05PM
Nov 6, 2024 04:05PM
Sep 25, 2024 09:00AM Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024
Sep 4, 2024 07:29AM
Sep 3, 2024 08:01AM
Sep 3, 2024 08:00AM
Aug 12, 2024 08:04AM
Aug 12, 2024 08:00AM
Aug 6, 2024 04:05PM
Jul 9, 2024 08:04AM Caribou Bioscience, Inc (CRBU) Appoints Terri Laufer to its Board
Jul 9, 2024 08:00AM
Jun 3, 2024 06:25AM
Jun 2, 2024 07:00PM
May 13, 2024 07:00AM
May 7, 2024 04:05PM
Apr 27, 2024 06:00AM
Apr 24, 2024 10:00AM Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 4, 2024 04:00PM
Apr 4, 2024 04:00PM
Mar 27, 2024 06:45AM
Mar 11, 2024 04:05PM
Jan 8, 2024 05:19AM
Jan 7, 2024 11:00AM
Dec 12, 2023 04:02PM Caribou Bioscience (CRBU) Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024
Dec 12, 2023 04:02PM
Dec 4, 2023 08:55AM
Nov 7, 2023 04:00PM
Nov 6, 2023 08:00AM
Oct 18, 2023 08:04AM
Oct 18, 2023 08:00AM
Aug 8, 2023 04:00PM Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Jul 13, 2023 04:01PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All